CooperCompanies Reports 2025 Third Quarter Revenue Growth, Updates Fiscal Year Financial Guidance

Published on August 28, 2025
SAN RAMON, Calif.—CooperCompanies (Nasdaq: COO), a medical device company, yesterday announced financial results for its fiscal third quarter ended July 31, 2025. In the quarter, CooperCompanies reported that overall revenue increased 6 percent year-over-year, 3 percent in constant currency, and 2 percent organically to $1,060.3 million. CooperVision (CVI) revenue was up 6 percent to $718.4 million, led by the sale of toric and multifocal contact lenses, and CooperSurgical (CSI) revenue was up 4 percent to $341.9 million, according to the announcement.
Continue reading on website
Other news

Eye care providers cite tariffs, inflation as major concerns in first half of 2025

August 27, 2025
As many as 9 in 10 providers reporting tariffs having the most strongly impacted wholesale eyewear prices, with 8 out of 10 providers stating that tariffs are affecting wholesale practice supplies.

Inside genetics and glaucoma

August 28, 2025
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.